ADIPOQ and cardiovascular disorder: We identified the TLR2 signaling pathway as most deregulated canonical pathway with IRAK3 as downregulated key inhibitor that is associated with obesity-associated metabolic syndrome and loss of protective action of adiponectin against cardiovascular disease.